Table 2.
Median survival (months) from diagnosis of stage IV recurrent melanoma in MSLT-I patients, based on treatment, number of organs involved, and number of individual metastases.
| Organ sites with metastases (N) |
Surgery | Non-surgical | P value | ||
|---|---|---|---|---|---|
| Median Survival (N) |
Percentage | Median Survival (N) |
Percentage | ||
| 1 (242) | 17.6 (144) | 60% | 7.5 (98) | 40% | <0.0001 |
| 2 (35) | 13.4 (14) | 40% | 6.6 (21) | 60% | 0.056 |
| ≥3 (14) | 4.5 (3) | 21% | 4.8 (11) | 79% | 0.36 |
|
Individual metastases |
|||||
| 1 (226) | 16.3 (134) | 59% | 7.5 (92) | 41% | <0.0001 |
| 2(43) | 17.1 (20) | 47% | 6.9 (23) | 53% | 0.0364 |
| ≥3 (22) | 13.9 (7) | 32% | 5.2 (15) | 68% | 0.085 |